North Shore Hematology Oncology Associates Pc

CLIA Laboratory Citation Details

2
Total Citations
7
Total Deficiencyies
2
Unique D-Tags
CMS Certification Number 33D2223211
Address 1500 Route 112, Building , Suite 102, Port Jefferson Station, NY, 11776
City Port Jefferson Station
State NY
Zip Code11776
Phone631 574-8396
Lab DirectorRIEM BADR

Citation History (2 surveys)

Survey - July 23, 2024

Survey Type: Standard

Survey Event ID: Y91611

Deficiency Tags: D5291 D6021 D6021

Summary:

Summary Statement of Deficiencies D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. This STANDARD is not met as evidenced by: Based on review of the Quality Assessment (QA) policy, QA record reviews, as well as interview with the Technical Supervisor (TS), the laboratory failed to comply with frequency of bi-annual QA performance review. FINDINGS: 1. There was no documentation of 2023 bi-annual QA review. 2. This was contrary to instructions indicated in the current, approved QA policy. 3. TS confirmed findings on July 23, 2024, at approximately 12:30 P.M. PLEASE NOTE: THIS IS A RECITED DEFICIENCY FROM SURVEY CONDUCTED JUNE 3, 2022. D6021 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(5) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(5) Ensure that quality assessment programs are established and maintained to assure the quality of laboratory services provided. This STANDARD is not met as evidenced by: Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- Based on review of the current, approved QA procedure, QA record reviews, as well as interview with the TS, the laboratory director (LD) failed to comply with QA for all phases for the general laboratory system. Refer to D5291. PLEASE NOTE: THIS IS A RECITED DEFICIENCY FROM SURVEY CONDUCTED ON JUNE 3, 2022. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - June 3, 2022

Survey Type: Standard

Survey Event ID: TDNO11

Deficiency Tags: D5291 D6021 D5291 D6021

Summary:

Summary Statement of Deficiencies D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. This STANDARD is not met as evidenced by: Based on review of the Quality Assessment (QA) policy, the laboratory failed to establish frequency of QA policy and perform QA review. FINDINGS: 1. 2021 annual QA documentation was not available for review. 2. 2021 annual QA review not performed confirmed with an interview with technical supervisor on 6/3/3022 about 11:30am. D6021 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(5) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(5) Ensure that quality assessment programs are established and maintained to assure the quality of laboratory services provided. This STANDARD is not met as evidenced by: Based on review of the laboratory's Quality Assessment (QA) procedure, it failed to establish frequency of QA review and confirmed in an interview with the laboratory Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- technical supervisor, the laboratory director failed to establish a written QA for all phases for the general laboratory system. Refer to D5291. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access